Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 2/20 | 0.41 |
| ▸ | GABRP known ✓ | O00591 | 1/20 | 0.41 |
| ▸ | GABRD known ✓ | O14764 | 1/20 | 0.41 |
| ▸ | GABBR2 known ✓ | O75899 | 1/20 | 0.41 |
| ▸ | GABRA1 known ✓ | P14867 | 1/20 | 0.41 |
| ▸ | GABRB1 known ✓ | P18505 | 1/20 | 0.41 |
| ▸ | GABRG2 known ✓ | P18507 | 1/20 | 0.41 |
| ▸ | GABRB3 known ✓ | P28472 | 1/20 | 0.41 |
| ▸ | GABRA5 known ✓ | P31644 | 1/20 | 0.41 |
| ▸ | GABRA3 known ✓ | P34903 | 1/20 | 0.41 |
| ▸ | GABRA2 known ✓ | P47869 | 1/20 | 0.41 |
| ▸ | GABRB2 known ✓ | P47870 | 1/20 | 0.41 |
| ▸ | GABRA4 known ✓ | P48169 | 1/20 | 0.41 |
| ▸ | GABRE known ✓ | P78334 | 1/20 | 0.41 |
| ▸ | GABRA6 known ✓ | Q16445 | 1/20 | 0.41 |
| ▸ | GABRG1 known ✓ | Q8N1C3 | 1/20 | 0.41 |
| ▸ | GABRG3 known ✓ | Q99928 | 1/20 | 0.41 |
| ▸ | GABBR1 known ✓ | Q9UBS5 | 1/20 | 0.41 |
| ▸ | GABRQ known ✓ | Q9UN88 | 1/20 | 0.41 |
| ▸ | BBOX1 | O75936 | 6/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2844095 | 0.98 | BBOX1 (0.45) | BBOX1TSHRLMNATHRBBLM | |
| SCHEMBL25408982 | 0.84 | TSHR (0.48) | BBOX1TSHRLMNATHRBBLM | |
| SCHEMBL9973818 | 0.84 | TSHR (0.52) | BBOX1TSHRLMNAALDH1A1APEX1 | |
| SCHEMBL14075503 | 0.81 | TSHR (0.50) | BBOX1TSHRLMNAKMT2AALDH1A1 | |
| SCHEMBL18407855 | 0.78 | BBOX1 (0.59) | BBOX1TSHRLMNATHRBBLM | |
| SCHEMBL9242040 | 0.77 | TSHR (0.46) | BBOX1TSHRLMNAALDH1A1APEX1 | |
| SCHEMBL13922325 | 0.77 | DNM1 (0.48) | BBOX1TSHRLMNAKMT2AALDH1A1 | |
| SCHEMBL14075508 | 0.76 | MEN1 (0.50) | BBOX1TSHRLMNAKMT2ANPSR1 | |
| Hydrochloric Acid SCHEMBL6427071 | 0.76 | ALDH1A1 (0.48) | BBOX1TSHRLMNAALDH1A1APEX1 | |
| SCHEMBL1537860 | 0.74 | HTT (0.58) | TSHRKMT2AALDH1A1HDAC11MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170158989-A1 | Multi-Purpose Cleaner | ROBINSON GREGORY E (US) | 2017-06-08 | — | — | US | claimed |
| US-20070269843-A1 | Diagnostic Assays That Use Mycobacteriophages | INTEGRATED RESEARCH TECHNOLOGY, LLC. | 2007-11-22 | — | — | US | claimed |
| US-7067500-B2 | Betaines as adjuvants to susceptibility testing and antimicrobial therapy | INTEGRATED RESEARCH TECHNOLOGY, LLC (US) | 2006-06-27 | — | — | US | claimed |
| WO-2005116243-A2 | IMPROVEMENTS TO DIAGNOSTIC ASSAYS THAT USE MYCOBACTERIOPHAGES | INTEGRATED RESEARCH TECHNOLOGY, LLC (US) | 2005-12-08 | — | — | WO | claimed |
| EP-0756633-B1 | METHOD AND KITS FOR PROCESSING MYCOBACTERIA AND MYCOLIC ACID CONTAINING BACTERIA | INTEGRATED RES TECHNOLOGY LLC (US) | 2005-06-08 | — | — | EP | claimed |
| EP-0980438-A4 | BETAINES AS ADJUDVANTS TO SUSCEPTIBILITY TESTING AND ANTIMICROBIAL THERAPY | INTEGRATED RES TECHNOLOGY LLC (US) | 2004-10-27 | — | — | EP | claimed |
| US-20030104513-A1 | Betaines as adjuvants to susceptibility testing and antimicrobial therapy | INTEGRATED RESEARCH TECHNOLOGY, LLC | 2003-06-05 | — | — | US | claimed |
| US-6406880-B1 | MYCOLIC ACID STRUCTURE IN OUTER MEMBRANE, ANTIBIOTIC AND BETAINE | INTEGRATED RESEARCH TECHNOLOGY, LLC | 2002-06-18 | — | — | US | claimed |
| EP-0980438-A1 | BETAINES AS ADJUDVANTS TO SUSCEPTIBILITY TESTING AND ANTIMICROBIAL THERAPY | Integrated Research Technology, LLC (US) | 2000-02-23 | — | — | EP | claimed |
| WO-1998050576-A1 | BETAINES AS ADJUVANTS TO SUSCEPTIBILITY TESTING AND ANTIMICROBIAL THERAPY | INTEGRATED RESEARCH TECHNOLOGY, LLC (US) | 1998-11-12 | — | — | WO | claimed |
| WO-2023091342-A1 | PRESERVATION SYSTEM FOR STABILIZING SPORE-FORMING MICROBIALS | PHIBRO ANIMAL HEALTH CORPORATION (US) | 2023-05-25 | — | — | WO | disclosed |
| US-20230151324-A1 | PRESERVATION SYSTEM FOR STABILIZING SPORE-FORMING MICROBIALS | PHIBRO ANIMAL HEALTH CORPORATION (US) | 2023-05-18 | — | — | US | disclosed |
| US-11370996-B2 | Compositions including keto-ester compounds and methods of using the same | FOURTH PRINCIPLE, LLC (US) | 2022-06-28 | — | — | US | disclosed |
| US-20200377823-A1 | COMPOSITIONS INCLUDING KETO-ESTER COMPOUNDS AND METHODS OF USING THE SAME | TALK ABOUT IT SOLUTIONS | 2020-12-03 | — | — | US | disclosed |
| EP-3728487-A2 | COMPOSITIONS INCLUDING KETO-ESTER COMPOUNDS AND METHODS OF USING THE SAME | Fourth Principle, LLC. (US) | 2020-10-28 | — | — | EP | disclosed |
| US-6004771-A | EXTRACTED MYCOBACTERIAL SAMPLE IS SUITABLE FOR DETECTION BY CULTURE AND AMPLIFICATION | INTEGRATED RESEARCH TECHNOLOGY, LLC (US) | 1999-12-21 | — | — | US | disclosed |
| US-5985593-A | DETERMINATION OF MICROORGANISM CONTAINING MYCOLIC ACID IN EXTERIOR MEMBRANE; ENZYME LYSIS | INTEGRATED RESEARCH TECHNOLOGY, L.L.C. (US) | 1999-11-16 | — | — | US | disclosed |
| US-5658749-A | DECREASING THE BUOYANCY OF MICROORGANISMS CONTAINING MYCOLIC ACID-LIKE STRUCTURES IN THE OUTER MEMBRANE USING A SOLUTION OF AN SB-18-LIKE OR ROD-LIKE DETERGENT; AMPHOTERIC SURFACTANTS; MEDICAL DIAGNOSIS; CULTURES; AMPLIFICATION | CORNING CLINICAL LABORATORIES, INC. (US) | 1997-08-19 | — | — | US | disclosed |
| CN-1150460-A | Method for processing mycobacteria | CORNING CLINICAL LAB INC (US) | 1997-05-21 | — | — | CN | disclosed |
| EP-0760402-A1 | Carbon dioxide steel corrosion inhibition with synergetic, environmental friendly composition of N-acyl sarcosines and N-alkyl-amidopropylbetaines | CECA S.A. (FR) | 1997-03-05 | — | — | EP | disclosed |